Skip to Content

MediPharm Labs Corp MEDIF

Morningstar Rating
$0.06 0.00 (3.38%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MEDIF is trading at a 51% discount.
Price
$0.06
Fair Value
$3.85
Uncertainty
Extreme
1-Star Price
$9.76
5-Star Price
$9.82
Economic Moat
Ypysf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MEDIF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.06
Day Range
$0.050.07
52-Week Range
$0.040.08
Bid/Ask
$0.06 / $0.07
Market Cap
$25.80 Mil
Volume/Avg
31,620 / 122,661

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.93
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
130

Valuation

Metric
MEDIF
Price/Earnings (Normalized)
Price/Book Value
0.61
Price/Sales
0.93
Price/Cash Flow
Price/Earnings
MEDIF

Financial Strength

Metric
MEDIF
Quick Ratio
2.11
Current Ratio
3.27
Interest Coverage
−59.45
Quick Ratio
MEDIF

Profitability

Metric
MEDIF
Return on Assets (Normalized)
−23.35%
Return on Equity (Normalized)
−30.91%
Return on Invested Capital (Normalized)
−28.16%
Return on Assets
MEDIF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AYbdkwyjfgyCwfy$77.2 Bil
MKKGY
Merck KGaA ADRVzfbttpfdGrqlr$75.4 Bil
HLN
Haleon PLC ADRRchptjlWjxp$38.1 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRVntkwvfxXbyqt$16.0 Bil
VTRS
Viatris IncWwcfylmqgWgb$14.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRLvvjnmbkbQqvg$12.1 Bil
CTLT
Catalent IncRcvjckpsFdsmzz$10.2 Bil
PRGO
Perrigo Co PLCJzqcglqQrb$4.3 Bil
CURLF
Curaleaf Holdings IncPbggvvtckHrh$4.0 Bil
PBH
Prestige Consumer Healthcare IncStfflcdJrlsfs$3.6 Bil

Sponsor Center